tiprankstipranks
Trending News
More News >
Aldeyra resubmits topical ocular reproxalap NDA to FDA
PremiumThe FlyAldeyra resubmits topical ocular reproxalap NDA to FDA
11d ago
Aldeyra Therapeutics Holds Annual Meeting with Key Votes
Premium
Company Announcements
Aldeyra Therapeutics Holds Annual Meeting with Key Votes
17d ago
Aldeyra Therapeutics: Strong Financial Position and Positive Trial Outcomes Drive Buy Rating
Premium
Ratings
Aldeyra Therapeutics: Strong Financial Position and Positive Trial Outcomes Drive Buy Rating
1M ago
Aldeyra’s reproxalap  achieves primary endpoint in Phase 3 dry eye disease trial
PremiumThe FlyAldeyra’s reproxalap achieves primary endpoint in Phase 3 dry eye disease trial
2M ago
Aldeyra Therapeutics Appoints Chip Clark to Board
Premium
Company Announcements
Aldeyra Therapeutics Appoints Chip Clark to Board
2M ago
Aldeyra options imply 12.1% move in share price post-earnings
Premium
The Fly
Aldeyra options imply 12.1% move in share price post-earnings
2M ago
Aldeyra Therapeutics: Buy Rating Affirmed Amid Promising Developments and Robust Financial Health
PremiumRatingsAldeyra Therapeutics: Buy Rating Affirmed Amid Promising Developments and Robust Financial Health
3M ago
Aldeyra Therapeutics Receives FDA Complete Response Letter
Premium
Company Announcements
Aldeyra Therapeutics Receives FDA Complete Response Letter
3M ago
Aldeyra options imply 35.3% move in share price post-earnings
Premium
The Fly
Aldeyra options imply 35.3% move in share price post-earnings
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100